prias-project.org

erspc.org

ERSPC Section: Belgium (Antwerp) - ERSPC

http://www.erspc.org/belgium

ERSPC European Randomized Study of Screening for Prostate Cancer. ERSPC Section: Belgium (Antwerp). Tel 32-3-338.91.54. Brigitte.dourcy-belle-rose@ocmw.antwerpen.be. Project leader: Louis Denis. Scientific advice: Jan Willem Coebergh. Data Handling: Vera Nelen. Causes of death committee:. Early detection of prostate diseases Antwerp Protocol. 31 The European program tries to evaluate the serum analysis of Prostate Specific Antigen (PSA) as a screening tool for prostate cancer in men aged 55 to 69 years.

erspc.org

Differences among men on active surveillance for very low-risk prostate cancer detected through population-based versus opportunistic prostate-specific antigen-screening. - ERSPC

http://www.erspc.org/publication/differences-among-men-on-active-surveillance-for-very-low-risk-prostate-cancer-detected-through-population-based-versus-opportunistic-prostate-specific-antigen-screening

ERSPC European Randomized Study of Screening for Prostate Cancer. Differences among men on active surveillance for very low-risk prostate cancer detected through population-based versus opportunistic prostate-specific antigen-screening. Randazzo M, Beatrice J, Huber A, Grobholz R, Manka L, Recker F, Kwiatkowski M. SWOP - Prostate Cancer Risk Calculator. ERSPC latest findings confirm increased mortality benefit from prostate cancer testing.

erspc.org

PSA - ERSPC

http://www.erspc.org/prostate-cancer/psa

ERSPC European Randomized Study of Screening for Prostate Cancer. The prostate is a small gland which surrounds the urethra. It is located underneath the bladder and in front of the rectum. One of the functions of the prostate is to produce and transport prostatic fluid. During an orgasm this fluid mixes with sperm and is ejaculated out of the penis. PSA (Prostate Specific Antigen) is a protein, found in the blood. It is produced exclusively by the prostate, but not exclusively by prostate cancer. 80% of...

erspc.org

Study Results Archives - ERSPC

http://www.erspc.org/news/study-results

ERSPC European Randomized Study of Screening for Prostate Cancer. February 22, 2017. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer. Haring A, Murtola TJ, Talala K, Taari K, Tammela TL, Auvinen A. Scand J Urol. 2017 Jan 13:1-11. October 14, 2014. Greater absolute benefit from PSA screening at 13 years of follow-up in the ERSPC trial not sufficient to justify population-based screening. The ERSPC is the largest randomized trial of screening ...

erspc.org

Meetings - ERSPC

http://www.erspc.org/members/meetings

ERSPC European Randomized Study of Screening for Prostate Cancer. This page is for members only. To view it, please enter your password below:. SWOP - Prostate Cancer Risk Calculator. ERSPC latest findings confirm increased mortality benefit from prostate cancer testing. PSA screening cuts deaths by 20%, says world’s largest prostate cancer study. Estimate of opportunistic prostate-specific antigen testing in the Finnish Randomized Study of Screening for Prostate Cancer.

erspc.org

Active Surveillance - ERSPC

http://www.erspc.org/prostate-cancer/active-surveillance

ERSPC European Randomized Study of Screening for Prostate Cancer. The ERSPC study indicates that over-diagnosis of prostate cancer, defined as the diagnosis of prostate cancer cases that might never surface clinically during life time, has been estimated to be as high as half of the cases diagnosed in the screening group. Active Surveillance potential alternative to surgery. As Prof Chris Bangma, an ERSPC director and chairman of the urology department at Erasmus Medical Center, Rotterdam, explained: Ove...

erspc.org

ERSPC Section: France (Toulouse/Montpellier) - ERSPC

http://www.erspc.org/france

ERSPC European Randomized Study of Screening for Prostate Cancer. ERSPC Section: France (Toulouse/Montpellier). Location of Administrative Centers:. ADIMEP (Association pour la Diffusion de la Médecine de Prévention),. 66 Chemin du Vallon B.P. 4420. Tel: 33 5 62 17 39 05. Fax : 33 5 62 17 39 01. ARCOU (Association de Recherche et de Consensus en. 119 avenue de Lodève. Tel : 04 67 75 97 57. Fax : 05 67 75 97 65. Service d’urologie CHRU 59037 LILLE. Téléphone : 03 20 44 42 35. Registre des cancers du Tarn.

erspc.org

ERSPC Background - ERSPC

http://www.erspc.org/prostate-cancer/erspc-background

ERSPC European Randomized Study of Screening for Prostate Cancer. Background to the work of the ERSPC. Views of Prof Louis Denis. Co-founder Prof Fritz Schröder commenting on. What are the risks of screening? What are the benefits of screening? What are the other ongoing studies worldwide that contribute to the questions of screening? What screening tests are used within the ERSPC? DRE: (digital rectal examination). PSA: (prostate specific antigen). Why are different screening intervals within the ERSPC?

erspc.org

Publications - ERSPC

http://www.erspc.org/publications

ERSPC European Randomized Study of Screening for Prostate Cancer. Estimate of opportunistic prostate-specific antigen testing in the Finnish Randomized Study of Screening for Prostate Cancer. Kilpeläinen TP, Pogodin-Hannolainen D, Kemppainen K, Talala K, Raitanen J, Taari K, Kujala P, Tammela TL, Auvinen A. Effect of 5-alfa reductase inhibitor usage on efficacy and accuracy of prostate cancer screening. Murtola TJ , Virkku A, Talala K , Stenman U-H, Taari K, Tammela TLJ, Auvinen A. Journal: Scand J Urol.

erspc.org

ERSPC Section: Italy (Florence) - ERSPC

http://www.erspc.org/italy

ERSPC European Randomized Study of Screening for Prostate Cancer. ERSPC Section: Italy (Florence). ISPO Cancer Research and Prevention Institute. Clinical and Descriptive Epidemiology Unit. Via delle Oblate 2,. 50141, Florence,. ISPO Cancer Research and Prevention Institute. Clinical and Descriptive Epidemiology Unit. Via delle Oblate 2, 50141, Florence,. Local ERSPC protocol foresees:. Randomisation (1:1) of resident males 55-69. PSA (tandem R Hybritech) determination. Local focus of interest. Effect of...